These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2477118

  • 1. Pharmacodynamics and proposed mechanism of therapeutic action and host toxicity of 9-beta-D-arabinofuranosyl-2-fluoroadenine monophosphate (F-araAMP) in P388 murine leukemia-bearing mice.
    Avramis VI.
    Cancer Invest; 1989; 7(2):129-37. PubMed ID: 2477118
    [Abstract] [Full Text] [Related]

  • 2. Metabolism of 9-beta-D-arabinosyl-2-fluoroadenine-5'-phosphate by mice bearing P388 leukemia.
    Avramis VI, Plunkett W.
    Cancer Drug Deliv; 1983; 1(1):1-10. PubMed ID: 6085754
    [Abstract] [Full Text] [Related]

  • 3. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
    Avramis VI, Plunkett W.
    Cancer Res; 1982 Jul; 42(7):2587-91. PubMed ID: 7083151
    [Abstract] [Full Text] [Related]

  • 4. Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-phosphate in mice and dogs.
    Noker PE, Duncan GF, El Dareer SM, Hill DL.
    Cancer Treat Rep; 1983 May; 67(5):445-56. PubMed ID: 6189605
    [Abstract] [Full Text] [Related]

  • 5. 2-fluoro-ATP: a toxic metabolite of 9-beta-D-arabinosyl-2-fluoroadenine.
    Avramis VI, Plunkett W.
    Biochem Biophys Res Commun; 1983 May 31; 113(1):35-43. PubMed ID: 6860342
    [Abstract] [Full Text] [Related]

  • 6. Comparison between the plasma and intracellular pharmacology of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in patients with relapsed leukemia.
    Danhauser L, Plunkett W, Liliemark J, Gandhi V, Iacoboni S, Keating M.
    Leukemia; 1987 Sep 31; 1(9):638-43. PubMed ID: 3478543
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The effect of 3,4-disuccinyldianhydrogalactitol, N-nitrosourea and their combination on DNA synthesis in normal and mouse P388 tumor cells].
    Sokolova IS, Veres Z, Jakus J, Otvos LL, Gorbacheva LB.
    Izv Akad Nauk SSSR Biol; 1989 Sep 31; (4):527-33. PubMed ID: 2794230
    [Abstract] [Full Text] [Related]

  • 11. Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy.
    Gandhi V, Estey E, Du M, Keating MJ, Plunkett W.
    Clin Cancer Res; 1997 Sep 31; 3(9):1539-45. PubMed ID: 9815841
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Modulation of arabinosylnucleoside metabolism by arabinosylnucleotides in human leukemia cells.
    Gandhi V, Plunkett W.
    Cancer Res; 1988 Jan 15; 48(2):329-34. PubMed ID: 3335008
    [Abstract] [Full Text] [Related]

  • 15. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia.
    Gandhi V, Estey E, Du M, Nowak B, Keating MJ, Plunkett W.
    Clin Cancer Res; 1995 Feb 15; 1(2):169-78. PubMed ID: 9815970
    [Abstract] [Full Text] [Related]

  • 16. 9-Beta-D-arabinofuranosyladenine 5'-monophosphate (araAMP) is converted directly to its antivirally active 5'-triphosphate form by 5-phosphoribosyl-1-pyrophosphate (PRPP) synthetase.
    Balzarini J, De Clercq E.
    Biochem Biophys Res Commun; 1990 Dec 31; 173(3):781-7. PubMed ID: 1702630
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K, Oka T, Morimoto M.
    Cancer Res; 1987 Mar 15; 47(6):1516-22. PubMed ID: 2434218
    [Abstract] [Full Text] [Related]

  • 18. Antitumor activity of 2-fluoro-2'-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylase.
    Parker WB, Allan PW, Hassan AE, Secrist JA, Sorscher EJ, Waud WR.
    Cancer Gene Ther; 2003 Jan 15; 10(1):23-9. PubMed ID: 12489025
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of decrease of protein synthesis by sodium cyanate in murine P388 leukemia cells.
    Lazarus P, Panasci LC.
    Cancer Res; 1987 Oct 01; 47(19):5102-7. PubMed ID: 3621195
    [Abstract] [Full Text] [Related]

  • 20. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model.
    Kühl JS, Sikic BI, Blume KG, Chao NJ.
    Exp Hematol; 1992 Oct 01; 20(9):1048-54. PubMed ID: 1468539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.